Coya Therapeutics Inc. Insider Trading

COYA

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Nov 2024.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Nov 2024

Nov 14, 2024

Get an email when COYA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Nov 14, 2024	David S Snyder Chief Financial Officer	Bought	1,800	$7.19	13K	26%	Form 4
Nov 13, 2024	Arun Swaminathan Chief Executive Officer	Bought	5,000	$7.36	37K	100%	Form 4
Nov 11, 2024	Fred Grossman Chief Medical Officer	Bought	2,710	$7.37	20K	New	Form 4
Nov 11, 2024	Arun Swaminathan Chief Executive Officer	Bought	5,000	$7.34	37K	New	Form 4

Nov 14, 2024
David S Snyder
Chief Financial Officer · bought 1,800 at $7.19
13K
26% of stake
Nov 13, 2024
Arun Swaminathan
Chief Executive Officer · bought 5,000 at $7.36
37K
100% of stake
Nov 11, 2024
Fred Grossman
Chief Medical Officer · bought 2,710 at $7.37
20K
New position
Nov 11, 2024
Arun Swaminathan
Chief Executive Officer · bought 5,000 at $7.34
37K
New position

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch COYA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with COYA

CompareIntrinsic value

ACRSAclaris Therapeutics, Inc.

$3.68-1.60%10

PULMPulmatrix Inc.

$1.52+14.29%40

ADAGAdagene Inc.

$2.41+2.55%25

ROIVRoivant Sciences Ltd

$38.23+6.08%16

ALMSAlumis Inc.

$6.55+0.77%10

PTNPalatin Technologies, Inc.

$6.02+15.33%50

NAMSNewAmsterdam Pharma Co. N.V.

$20.93+5.18%10

KZRKezar Life Sciences, Inc.

No recent price20

Held by ETFs

COYA is in 1 US ETF. The largest of them, with COYA's weight in each:

iShares Micro-Cap ETFIWC0.02%of the fund

Spot a number that looks wrong? Check it in COYA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing COYA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.